Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

• Cristiano Ferrario ,

  * E-mail: cristianoferrario@gmail.com (CF); Khashayar.esfahani@mail.mcgill.ca (KE)

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  ⨯
• Ivan Strepponi,

  Affiliation Department of Cell Therapeutics, Sede Secondaria Della Cell Therapeutics, Bresso, Italy

  ⨯
• Khashayar Esfahani ,

  * E-mail: cristianoferrario@gmail.com (CF); Khashayar.esfahani@mail.mcgill.ca (KE)

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  http://orcid.org/0000-0003-2221-3755

  ⨯
• Helen Charamis,

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  ⨯
• Adrian Langleben,

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  ⨯
• Emanuela Scarpi,

  Affiliation Department of statistics, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rome, Italy

  ⨯
• Oriana Nanni,

  Affiliation Department of statistics, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rome, Italy

  ⨯
• Wilson H. Miller Jr,

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  ⨯
• Lawrence C. Panasci

  Affiliation Department of Medical Oncology, McGill University, Montreal, Canada

  ⨯